Clinical Trial Update: Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial evaluating XRD-0394 in combination with radiation therapy for high-grade glioma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• XRD-0394

Snippet

Sponsor: NYU Langone Health | Conditions: High-Grade Glioma | EARLY_Phase 1 | Status: RECRUITING